Welcome to the LEOSS.sero-survey
The platform for seroprevalence studies on SARS-CoV-2
The LEOSS.sero-survey platform is a crucial and independent infrastructure to accelerate research about the seroprevalence of SARS-CoV-2. Researchers, government and industry partners are invited to contribute their knowledge and tools to improve evidence-based decision-making on COVID-19. LEOSS stands for Lean European Open Survey on SARS-CoV‑2, see for more details LEOSS.net.
Locations of participating SARS-CoV-2 seroprevalence studies
The LEOSS.sero-survey focuses on four primary aims about seroprevalence of SARS-CoV-2: a community platform for researcher, a platform for critical appraisal of diagnostic trials, a platform of study related documents and a cloud based meta analysis platform
The LEOSS.sero-survey platform is an open intiative to provide a centralised hub of resources. Researchers can submit SARS-Cov-2 seroprevalence studies, publications, and even data to be included here.Contribute
Stay up to date
Stay up to date with the latest opportunities to collaborate on SARS-Cov-2 seroprevalence studies.
Find out about participating SARS-Cov-2 seroprevalence studies.
Preprints and peer-reviewed scientific papers about SARS-Cov-2 seroprevalence studies.